2008 - Review: Azathioprine, infliximab, certolizumab, and adalimumab are effective for maintaining remission in Crohn disease

Marshall, John K.
June 2008
ACP Journal Club;6/20/2008, Vol. 148 Issue 4, p8
Academic Journal
The article discusses interventions that are effective for maintaining remission in Crohn disease. Meta-analysis showed that azathioprine and omega-3 fatty acids were more effective than placebo for maintaining remission. It is concluded that azathioprine, methotrexate, infliximab, certolizumab, adalimumab, natalizumab, enteral nutrition, and omega-3 fatty acids are effective for maintaining remission in Crohn disease.


Related Articles

  • Omega-3 Free Fatty Acids for the Maintenance of Remission in Crohn's Disease. Robinson, Malcolm // Internal Medicine Alert;6/15/2008, Vol. 30 Issue 11, p81 

    The article reports on omega-3 fatty acids to prevent Crohn's disease relapse.

  • A Different Kind of Fish Story. Kuritzky, Louis // Internal Medicine Alert;11/29/2012, Vol. 34 Issue 22, p176 

    The article focuses on a study based on meta-analysis according to which that was not any confirmation of any positive effects of omega-3 fatty acids.

  • Omega-3s: state of the science. Runestad, Todd // Functional Ingredients;Oct2012, Issue 123, p6 

    In this article the author offers his opinions on several research studies which have investigated the health benefits of consuming omega-3 fatty acid supplements and concluded that they did not improve certain health conditions. Support for the use of omega-3 supplements which has been voiced...

  • The impact of omega-3 polyunsaturated fatty acid supplementation on the incidence of cardiovascular events and complications in peripheral arterial disease: a systematic review and meta-analysis. Enns, Jennifer E.; Yeganeh, Azadeh; Zarychanski, Ryan; Abou-Setta, Ahmed M.; Friesen, Carol; Zahradka, Peter; Taylor, Carla G. // BMC Cardiovascular Disorders;2014, Vol. 14 Issue 1, p1 

    Background Individuals with peripheral arterial disease are at higher risk for cardiovascular events than the general population. While supplementation with omega-3 polyunsaturated fatty acids (PUFA) has been shown to improve vascular function, it remains unclear if supplementation decreases...

  • Omega-3 Polyunsaturated Fatty Acids: Structural and Functional Effects on the Vascular Wall. Zanetti, Michela; Grillo, Andrea; Losurdo, Pasquale; Panizon, Emiliano; Mearelli, Filippo; Cattin, Luigi; Barazzoni, Rocco; Carretta, Renzo // BioMed Research International;8/2/2015, Vol. 2015, p1 

    Omega-3 polyunsaturated fatty acids (n-3 PUFA) consumption is associated with reduced cardiovascular disease risk. Increasing evidence demonstrating a beneficial effect of n-3 PUFA on arterial wall properties is progressively emerging. We reviewed the recent available evidence for the...

  • Fish and Marine Omega-3 Polyunsatured Fatty Acid Consumption and Incidence of Type 2 Diabetes: A Systematic Review and Meta-Analysis. Ming Zhang; Eliane Picard-Deland; AndrĂ© Marette // International Journal of Endocrinology;2013, p1 

    Objective. To examine the association between fish and marine long-chain omega-3 polyunsaturated fatty acid (LC n-3 PUFA) consumption and incidence of type 2 diabetes (T2D) in prospective cohort studies. Methods. Meta-analytic procedures were used to estimate the relative risk (RR) using random...

  • Omega-3 Fatty Acid Supplementation and Cardiovascular Disease Events. Lewis, Evan J. H.; Sethi, Ankur; Singh, Mukesh; Arora, Rohit; Vlachopoulos, Charalambos; Richter, Dimitrios; Stefanadis, Christodoulos; Galli, Claudio; Brenna, J. Thomas; Rizos, Evangelos C.; Ntzani, Evangelia E. // JAMA: Journal of the American Medical Association;1/2/2013, Vol. 309 Issue 1, p27 

    Several letters to the editor is presented in response to the article "Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis" by E.C. Rizos and colleagues in a 2012 issue of the periodical along with response...

  • Omega-3 Polyunsaturated Fatty Acids: The Way Forward in Times of Mixed Evidence. Weylandt, Karsten H.; Serini, Simona; Chen, Yong Q.; Su, Hui-Min; Lim, Kyu; Cittadini, Achille; Calviello, Gabriella // BioMed Research International;8/2/2015, Vol. 2015, p1 

    Almost forty years ago, it was first hypothesized that an increased dietary intake of omega-3 polyunsaturated fatty acids (PUFA) from fish fat could exert protective effects against several pathologies. Decades of intense preclinical investigation have supported this hypothesis in a variety of...

  • Omega-3 Fatty Acids in Early Prevention of Inflammatory Neurodegenerative Disease: A Focus on Alzheimer's Disease. Thomas, J.; Thomas, C. J.; Radcliffe, J.; Itsiopoulos, C. // BioMed Research International;8/2/2015, Vol. 2015, p1 

    Alzheimer's disease (AD) is the leading cause of dementia and the most common neurodegenerative disease in the elderly. Furthermore, AD has provided the most positive indication to support the fact that inflammation contributes to neurodegenerative disease. The exact etiology of AD is unknown,...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics